rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Max Rosett

Chief Financial Officer

Company insider

Files Form 4 as: Chief Financial Officer, Immunome.

Every Form 4 they filed

In numbers

Trades disclosed
29
Buys
0
Sells
3
Bought
$0
Sold
$5.3M
Companies
1
Companies where not an officer
0
First trade
31 Jan 2024
Last trade
23 Jul 2026
Last filed
27 Jul 2026

Companies traded

Where they are an officer
IMNM ImmunomeOfficer · Biotechnology · last 23 Jul 20260 buys · 3 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
10Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
23 Jul 2026filed 27 Jul 2026IMNM ImmunomeBiotechnologySEC FORM 4 Code A—47,250 at $0.00filing
23 Jul 2026filed 27 Jul 2026IMNM Immunomeoption or derivative · BiotechnologySEC FORM 4 Code A—94,500 at $0.00filing
23 Jul 2026filed 27 Jul 2026IMNM Immunomeoption or derivative · BiotechnologySEC FORM 4 Code A—94,500 at $0.00filing
23 Jul 2026filed 27 Jul 2026IMNM ImmunomeBiotechnologySEC FORM 4 Code A—47,250 at $0.00filing
15 Jun 2026filed 17 Jun 2026IMNM ImmunomeBiotechnologySEC FORM 4 Code M$63K60,000 at $1.05filing
15 Jun 2026filed 17 Jun 2026IMNM ImmunomeBiotechnologySEC FORM 4 Sold$1.1M60,000 at $18.23filing
15 Jun 2026filed 17 Jun 2026IMNM Immunomeoption or derivative · BiotechnologySEC FORM 4 Code M—60,000 at $0.00filing
15 Jun 2026filed 17 Jun 2026IMNM Immunomeoption or derivative · BiotechnologySEC FORM 4 Code M—60,000 at $0.00filing
15 Jun 2026filed 17 Jun 2026IMNM ImmunomeBiotechnologySEC FORM 4 Code M$63K60,000 at $1.05filing
15 Jun 2026filed 17 Jun 2026IMNM ImmunomeBiotechnologySEC FORM 4 Sold$1.1M60,000 at $18.23filing
2 Apr 2026filed 3 Apr 2026IMNM ImmunomeBiotechnologySEC FORM 4 Code M$33K31,848 at $1.05filing
2 Apr 2026filed 3 Apr 2026IMNM ImmunomeBiotechnologySEC FORM 4 Code M$54K39,713 at $1.35filing
2 Apr 2026filed 3 Apr 2026IMNM ImmunomeBiotechnologySEC FORM 4 Sold$1.4M63,656 at $21.91filing
2 Apr 2026filed 3 Apr 2026IMNM Immunomeoption or derivative · BiotechnologySEC FORM 4 Code M—31,848 at $0.00filing
2 Apr 2026filed 3 Apr 2026IMNM Immunomeoption or derivative · BiotechnologySEC FORM 4 Code M—39,713 at $0.00filing
2 Apr 2026filed 3 Apr 2026IMNM ImmunomeBiotechnologySEC FORM 4 Sold$30K1,344 at $22.48filing
2 Apr 2026filed 3 Apr 2026IMNM Immunomeoption or derivative · BiotechnologySEC FORM 4 Code M—31,848 at $0.00filing
2 Apr 2026filed 3 Apr 2026IMNM Immunomeoption or derivative · BiotechnologySEC FORM 4 Code M—39,713 at $0.00filing
2 Apr 2026filed 3 Apr 2026IMNM ImmunomeBiotechnologySEC FORM 4 Code M$33K31,848 at $1.05filing
2 Apr 2026filed 3 Apr 2026IMNM ImmunomeBiotechnologySEC FORM 4 Code M$54K39,713 at $1.35filing

News

Arbutus Biopharma (NASDAQ:ABUS) vs. Immunome (NASDAQ:IMNM) Financial ComparisonIMNM · themarketsdaily.com · 12 Oct 2026

0 headlines in the last 90 days name Max Rosett; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.

Sectors

Health Care3

Buys in green, sells in red, by the company’s sector.

Related people

Jack HigginsChief Scientific Officer · Chief Scientific Officer at Immunome, filing Form 4 there in the last year
Isaac BarchasDirector · Director at Immunome, filing Form 4 there in the last year
Kinney HornChief Business Officer · Chief Business Officer at Immunome, filing Form 4 there in the last year
Philip TsaiChief Technical Officer · Chief Technical Officer at Immunome, filing Form 4 there in the last year
Sandra G. StonemanChief Legal Officer & Gc · Chief Legal Officer & Gc at Immunome, filing Form 4 there in the last year